Detalhe da pesquisa
1.
Failure to achieve 2-log10 viral decrease in first four weeks of peg-IFNalpha-2b plus ribavirin therapy for chronic hepatitis C with genotype 1b and high viral titer is useful in predicting non-response: evaluation of response-guided therapy.
Hepatogastroenterology
; 58(107-108): 965-70, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21830425